Blood Transfusion Diagnostics Market Analysis

  • Report ID: 4481
  • Published Date: Jul 29, 2024
  • Report Format: PDF, PPT

Blood Transfusion Diagnostics Market Analysis

Application (Blood Group Typing, Blood Screening)

The blood transfusion diagnostics market is segmented and analyzed for demand and supply by application into blood group typing and blood screening. Out of the two, the blood screening segment is anticipated to hold the largest market size by the end of 2036. Rising blood donations and transfusions are likely to boost the growth of the segment. By the statistics of the WHO, about 119 million of blood is donated every year all around the world. In addition, the growing penetration of sexually transmitted diseases, hepatitis B, and HIV are driving the segment’s growth. According to the Centers for Disease Control and Prevention, around 296 million people are living with hepatitis B worldwide. Moreover, as per the World Health Organization, the prevalence of STDs has impacted more than 1 million people all over the world.

End-user (Hospital Based Laboratories, Blood Banks)

The global blood transfusion diagnostics market is also segmented and analyzed for demand and supply by end-user in hospital-based laboratories and blood banks. Out of these segments, hospital-based laboratories are projected to secure a higher market share by 2036. This can be owed to the fact that hospital-based laboratories are better equipped to conduct the complicated and crucial screening procedures necessary for blood transfusions since they are furnished with cutting-edge machinery and technology and operated by qualified personnel. Additionally, these labs are in a good position to provide patients with a variety of diagnostic services such as blood typing. Also, hospitals are expanding their diagnostic capabilities to satisfy the rising need for blood products as the demand for blood transfusions rises. For instance, it was found that there were about 6100 hospitals in the U.S. in 2022.

Our in-depth analysis of the global market includes the following segments:

      By Product Type

  • Instruments
  • Reagents & Kits

       By Application

  • Blood Group Typing
  • Blood Screening

        By End-User

  • Hospital Based Laboratories
  • Blood Banks
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4481
  • Published Date: Jul 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of blood transfusion diagnostics is evaluated at USD 4.29 Billion.

The blood transfusion diagnostics market size was valued at USD 4.15 Billion in 2023 and is anticipated to exceed USD 6.74 Billion by the end of 2036, expanding at over 3.8% CAGR during the forecast period i.e., between 2024-2036. Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease are the few factors likely to propel the market growth.

Asia Pacific is poised to hold majority industry share by 2036, driven by aspects such as the rising need for blood transfusions, developing healthcare infrastructure in the area, and rising public awareness of the value of blood donation and testing.

Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample